Peragine, N., De Propris, M. S., Intoppa, S., Milani, M. L., Mariglia, P., Mauro, F. R., . . . Guarini, A. (2020). Modulated expression of adhesion, migration and activation molecules may predict the degree of response in chronic lymphocytic leukemia patients treated with ibrutinib plus rituximab. Haematologica.
Chicago Style CitationPeragine, Nadia, et al. "Modulated Expression of Adhesion, Migration and Activation Molecules May Predict the Degree of Response in Chronic Lymphocytic Leukemia Patients Treated With Ibrutinib Plus Rituximab." Haematologica 2020.
Cita MLAPeragine, Nadia, et al. "Modulated Expression of Adhesion, Migration and Activation Molecules May Predict the Degree of Response in Chronic Lymphocytic Leukemia Patients Treated With Ibrutinib Plus Rituximab." Haematologica 2020.